Natco Pharma
Date 12.09.2024
Natco Pharma
Timeframe : Weekly
Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Natco Pharma cash from the operating activity was Rs 1,196.40 Cr.
Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Natco Pharma has a Debt to Equity ratio of 0.06 , which is a strong indication for the company.
EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Natco Pharma , the EPS growth was 109.10 % which is good for the company.
Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Natco Pharma has OPM of 45.87 % which is a good sign for profitability.
ROE: Natco Pharma have a healthy ROE of 25.38 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Regards,
Ankur
Natco Pharma
Timeframe : Weekly
Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Natco Pharma cash from the operating activity was Rs 1,196.40 Cr.
Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Natco Pharma has a Debt to Equity ratio of 0.06 , which is a strong indication for the company.
EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Natco Pharma , the EPS growth was 109.10 % which is good for the company.
Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Natco Pharma has OPM of 45.87 % which is a good sign for profitability.
ROE: Natco Pharma have a healthy ROE of 25.38 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Regards,
Ankur
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.